Partners David Shore and Jeremy Younkin will attend the Longevity Summit’s annual event. The event gathers the entire longevity ecosystem to tackle the aging problem: longevity entrepreneurs, existing pharma and biotech companies, investors, researchers, and government organizations. Developing aging interventions may represent the largest value creation journey in human history, and it’s going to require a coordinated industry.
Developing aging therapies requires both new science and new business models. The Longevity Summit will explore the key topics that leaders within the industry need to know in order to turn longevity research into prescribable medicine. The event will explore the following topics:
Join us as we explore the following topics:
- Drug Discovery
- Regulatory Approval
- Clocks, Biomarkers, and Age Measurement
- Longevity Medicine
- Data Collection
- Longevity Clinical Trials
- Funding Longevity Biotech
- Replacement Strategies
- Regenerative Medicine
- Gene Editing & CRISPR
- The Root Causes of Aging
- Public Perception
